VEE Stock Overview
Provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VEE from our risk checks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Veeva Systems Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$197.20 |
| 52 Week High | US$241.40 |
| 52 Week Low | US$159.20 |
| Beta | 1.05 |
| 1 Month Change | -8.24% |
| 3 Month Change | -4.78% |
| 1 Year Change | 1.89% |
| 3 Year Change | 7.06% |
| 5 Year Change | n/a |
| Change since IPO | -14.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| VEE | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -0.7% | 0.3% | 4.6% |
| 1Y | 1.9% | -4.3% | 8.0% |
Return vs Industry: VEE exceeded the German Healthcare Services industry which returned -6.5% over the past year.
Return vs Market: VEE underperformed the German Market which returned 4.8% over the past year.
Price Volatility
| VEE volatility | |
|---|---|
| VEE Average Weekly Movement | 5.5% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in DE Market | 12.6% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: VEE has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: VEE's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 7,291 | Peter Gassner | www.veeva.com |
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics.
Veeva Systems Inc. Fundamentals Summary
| VEE fundamental statistics | |
|---|---|
| Market cap | €32.24b |
| Earnings (TTM) | €632.80m |
| Revenue (TTM) | €2.43b |
50.7x
P/E Ratio13.2x
P/S RatioIs VEE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VEE income statement (TTM) | |
|---|---|
| Revenue | US$2.75b |
| Cost of Revenue | US$699.64m |
| Gross Profit | US$2.05b |
| Other Expenses | US$1.33b |
| Earnings | US$714.14m |
Last Reported Earnings
Jan 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.39 |
| Gross Margin | 74.53% |
| Net Profit Margin | 26.00% |
| Debt/Equity Ratio | 0% |
How did VEE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/15 05:35 |
| End of Day Share Price | 2025/04/15 00:00 |
| Earnings | 2025/01/31 |
| Annual Earnings | 2025/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Veeva Systems Inc. is covered by 45 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Ishan Majumdar | Baptista Research |
| Saket Kalia | Barclays |